Not all sufferers with CLL need therapy. In spite of all recent developments, the iwCLL still suggests watchful observation for patients with asymptomatic illness.86 This recommendation is based on at least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Lengkapi formulir pendaftaran yang https://aloisa964tcj2.sunderwiki.com/user